A5080570873- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Heart Failure Treatment and Management
- Hip and Femur Fractures
- Congenital Heart Disease Studies
- Telemedicine and Telehealth Implementation
- Geriatric Care and Nursing Homes
- Clinical Nutrition and Gastroenterology
- Biomedical and Engineering Education
University of Utah
2016-2024
George E. Wahlen Department of VA Medical Center
2024
Intermountain Healthcare
2022
Background: Centrifugal-flow left ventricular assist devices (CF-LVADs) have improved morbidity and mortality for their recipients. Hospital readmissions remain common, negatively impacting quality of life survival. We sought to identify risk factors associated with hospital among patients CF-LVADs. Methods: Consecutive receiving a CF-LVAD between February 2011 March 2021 were retrospectively evaluated using prospectively maintained institutional databases. within three years post-LVAD...
Introduction: Existing models predicting right ventricular failure (RVF) after durable left assist device (LVAD) support are limited due to lack of multicenter validation, absence intraoperative characteristics, and marginal predictive power. We sought derive validate a risk model predict post-LVAD RVF. Methods: Advanced heart (HF) patients (N=798) requiring continuous-flow LVAD were enrolled at the Utah Transplant Affiliated Hospitals (n=477), Inova Heart & Vascular Institute (n=183),...
Introduction: Although significant cardiac reverse remodeling is a prerequisite for left ventricular (LV) assist device (LVAD) patient to be considered weaning, multiple factors including goals, physician comfort, and center experience, weigh in on this complex decision. Existing predictive models defining recovery as removal may under detect patients that could benefit from targeted bridge strategy. We sought derive validate tool identify prone remodel, independent of the decision explant....